General
PNG facing AstraZeneca vaccine hesitancy as some locals refuse to take jab amid rollout
Australia’s decision to limit the use of the AstraZeneca vaccine in people under 50 has created vaccine hesitancy in Papua New Guinea, where the government is continuing with its rollout of the jab.
Key points:
- As many as 8442 people have been infected with COVID-19 in the country and 69 people have died
- Many in PNG want more evidence the AstraZeneca vaccine is safe.
- Health experts insist dangerous side effects are very rare
Evidence that use of the vaccine can lead to very rare blood clots in people under 50 has given some citizens more uncertainty about its safety.
But PNG’s population is overwhelmingly young. The average age is just 22 and AstraZeneca is the only vaccine currently available in the country, where COVID-19…
-
Business21 hours agoWhy Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher
-
General18 hours agoThe ‘critical’ data that could greenlight next rate cut
-
General17 hours agoReport finds 2032 Brisbane Olympic and Paralympic Games could bring $70 billion in economic opportunities
-
Noosa News22 hours agoCharges laid over photo of kids ‘bound with tape, held at gunpoint’